Author

Chien‐Kuang Cornelia Ding

University of California, San FranciscoORCID 0000-0001-9047-0222Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Aishwarya SubramanianiD· 1 shared Arun P. WiitaiD· 1 shared Bradley A. StohriD· 1 shared Corynn KasapiD· 1 shared David Alan QuigleyiD· 1 shared Elizabeth Yip· 1 shared Eric Jay SmalliD· 1 shared Eric Li-Len FengiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aishwarya SubramanianORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedJun 17, 2025

Histologic variants in bladder cancer harbor aggressive molecular features including TM4SF1 expression and a CA125+ cell state

Heiko Yang, Hanbing Song, Elizabeth Yip…·Franklin W. Huang

Single cell RNA sequencing of bladder cancer subtypes identified a CA125+ cell state linked to aggressive features and TM4SF1 as a therapeutic target.

16 citationstop 1%

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 2, 2024

A prostate cancer gastrointestinal transcriptional phenotype may be associated with diminished response to AR-targeted therapy

Aishwarya Subramanian, Meng Zhang, Marina Nasrin Sharifi…·Martin Sjöström

This study identifies a gastrointestinal gene expression phenotype in metastatic castration-resistant prostate cancer that correlates with reduced response to androgen receptor inhibitors.

DOI 10.1101/2024.06.02.595931

humanbulk RNA-seq

𝕏 PostBluesky